Tumors Provoke Inflammation and Perineural Microlesions at Adjacent Peripheral Nerves.
dendritic cells
macrophage
microlesions
perineurium
sciatic nerve
tumor pain
Journal
Cells
ISSN: 2073-4409
Titre abrégé: Cells
Pays: Switzerland
ID NLM: 101600052
Informations de publication
Date de publication:
29 01 2020
29 01 2020
Historique:
received:
13
12
2019
revised:
23
01
2020
accepted:
25
01
2020
entrez:
5
2
2020
pubmed:
6
2
2020
medline:
11
2
2021
Statut:
epublish
Résumé
Cancer-induced pain occurs frequently in patients when tumors or their metastases grow in the proximity of nerves. Although this cancer-induced pain states poses an important therapeutical problem, the underlying pathomechanisms are not understood. Here, we implanted adenocarcinoma, fibrosarcoma and melanoma tumor cells in proximity of the sciatic nerve. All three tumor types caused mechanical hypersensitivity, thermal hyposensitivity and neuronal damage. Surprisingly the onset of the hypersensitivity was independent of physical contact of the nerve with the tumors and did not depend on infiltration of cancer cells in the sciatic nerve. However, macrophages and dendritic cells appeared on the outside of the sciatic nerves with the onset of the hypersensitivity. At the same time point downregulation of perineural tight junction proteins was observed, which was later followed by the appearance of microlesions. Fitting to the changes in the epi-/perineurium, a dramatic decrease of triglycerides and acylcarnitines in the sciatic nerves as well as an altered localization and appearance of epineural adipocytes was seen. In summary, the data show an inflammation at the sciatic nerves as well as an increased perineural and epineural permeability. Thus, interventions aiming to suppress inflammatory processes at the sciatic nerve or preserving peri- and epineural integrity may present new approaches for the treatment of tumor-induced pain.
Identifiants
pubmed: 32013137
pii: cells9020320
doi: 10.3390/cells9020320
pmc: PMC7072456
pii:
doi:
Substances chimiques
Lipids
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Déclaration de conflit d'intérêts
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Références
Diabetes. 2013 Jan;62(1):1-8
pubmed: 23258903
Cell Mol Immunol. 2018 Apr;15(4):346-352
pubmed: 29563613
Cells. 2019 May 11;8(5):
pubmed: 31083487
Cell. 2009 Oct 16;139(2):267-84
pubmed: 19837031
Genes Dev. 2003 Oct 1;17(19):2450-64
pubmed: 14522948
Pain. 1999 Sep;82(3):263-74
pubmed: 10488677
Proc Natl Acad Sci U S A. 2009 Aug 4;106(31):13076-81
pubmed: 19620723
Mol Cell Proteomics. 2008 Dec;7(12):2475-85
pubmed: 18753128
Proc Natl Acad Sci U S A. 2013 May 14;110(20):8242-7
pubmed: 23630268
J Cell Biol. 2018 Apr 2;217(4):1353-1368
pubmed: 29434029
Anticancer Res. 2005 Nov-Dec;25(6B):3905-15
pubmed: 16312045
Cancer Res. 1975 Jan;35(1):218-24
pubmed: 1109790
Nat Immunol. 2012 Mar 18;13(4):343-51
pubmed: 22430787
Proc Natl Acad Sci U S A. 2001 May 22;98(11):6494-9
pubmed: 11371650
J Neurochem. 2012 Dec;123(5):662-7
pubmed: 22849425
Nat Med. 2011 Oct 30;17(11):1498-503
pubmed: 22037646
Talanta. 2020 Mar 1;209:120593
pubmed: 31892006
J Pain Symptom Manage. 1997 Aug;14(2):99-117
pubmed: 9262040
Front Immunol. 2018 Apr 05;9:527
pubmed: 29675018
J Invest Dermatol. 2017 Mar;137(3):686-695
pubmed: 27818280
J Biol Chem. 1991 Jun 15;266(17):11341-6
pubmed: 2040638
Nat Rev Neurosci. 2006 Oct;7(10):797-809
pubmed: 16988655
Int J Mol Sci. 2017 Nov 01;18(11):
pubmed: 29104252
Comp Med. 2008 Jun;58(3):220-33
pubmed: 18589864
Cancer Res. 2017 Nov 15;77(22):6400-6414
pubmed: 28951461
Nat Rev Cancer. 2002 Mar;2(3):201-9
pubmed: 11990856
Nat Rev Immunol. 2017 Sep;17(9):559-572
pubmed: 28555670
Int J Cancer. 1975 Aug 15;16(2):255-65
pubmed: 1150353
Pain. 2002 Sep;99(1-2):167-74
pubmed: 12237194
Mediators Inflamm. 2016;2016:6058147
pubmed: 26966341